Source: Annual Congress 2003 - Airway mediators and responses
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Micheletto, C. Pomari, S. Tognella, F. Trevisan, R. W. Dal Negro (Bussolengo, Italy). Effects on bronchial response to methacholine of BDP-HFA and BDP-CFC. Eur Respir J 2003; 22: Suppl. 45, 3005

Member's Comments

No comment yet.

Related content which might interest you: Effect of inhaled salmeterol or fluticasone on organic dust induced bronchial hyperreactivity Source: Eur Respir J 2002; 20: Suppl. 38, 308s Year: 2002 Effect of montelukast or salmeterol added to inhaled fluticasone on response to albuterol in children with exercise-induced bronchoconstriction Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009 Protection against methacholine-induced bronchospasm: salbutamol pMDI versus Clickhaler(R) DPI Source: Eur Respir J 2003; 21: 816-820 Year: 2003 Attenuation of exercise-induced bronchoconstriction with montelukast or salmeterol added to inhaled fluticasone in children Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009 Reliever effect of extrafine BDP/F DPI in asthmatic patients after methacholine challenge Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 Comparison of the bronchoprotective effects of two salbutamol suplphate HFA pMDI using methacholine challenge testing Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II Year: 2011 Protective effect of inhaled beclomethasone dipropionate (BDP) in asthmatic patients with exercise-induced bronchoconstriction (EIB) Source: Eur Respir J 2002; 20: Suppl. 38, 306s Year: 2002 Effect of formoterol with or without budesonide in repeated low-dose allergen challenge Source: Eur Respir J 2009; 33: 747-753 Year: 2009 Protection by formoterol and salmeterol on bronchoconstriction provoked by methacholine and AMP in asthmatics Source: Eur Respir J 2002; 20: Suppl. 38, 307s Year: 2002 Comparison between fluticasone and salmeterol plus fluticasone on functional responses and sputum eosinophilia induced by allergen challenge Source: Eur Respir J 2005; 26: Suppl. 49, 123s Year: 2005 Influence of tiotropium bromide and formoterol on bronchial hyperresponsiveness in COPD Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 Sustained reduction of bronchial hyperresponsiveness with inhaled fluticasone propionate in mild asthma within three days Source: Eur Respir J 2002; 20: Suppl. 38, 197s Year: 2002 Airway responsiveness to methacholine and deep inhalations in rhinitic subjects Source: Eur Respir J 2006; 28: Suppl. 50, 218s Year: 2006 Influence of a low dose of BDP-HFA on methacholine or exercise-induced lung hyperinflation in mild asthma Source: Eur Respir J 2005; 26: Suppl. 49, 508s Year: 2005 The effect of inhaled budesonide and formoterol on bronchial remodeling in young asthmatics Source: Eur Respir J 2006; 28: Suppl. 50, 208s Year: 2006 Effects of ciclesonide and fluticasone propionate on allergen-induced chronic airway inflammation and bronchial hyperreactivity in sensitized brown-Norway rats Source: Eur Respir J 2003; 22: Suppl. 45, 280s Year: 2003 Esomeprazole 80 mg single-dose improves the bronchial response to MCh in non atopic GER-related asthma Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population Year: 2005 Montelukast plus inhaled budesonide versus double dose inhaled budesonide in nonasthmatic eosinophilic bronchitis Source: Annual Congress 2011 - Asthma: control and treatment Year: 2011 Bronchial hyperresponsiveness to methacholine/AMP and the bronchodilator response in asthmatic children Source: Eur Respir J 2011; 37: 800-805 Year: 2011 Duration of effect of single-dose inhaled fluticasone propionate on AMP-induced bronchoconstriction Source: Eur Respir J 2004; 23: 559-564 Year: 2004